| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Richard Nolan Townsend is Chief Executive Officer at LXEO. Richard Nolan Townsend's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Our model assigns Richard Nolan Townsend a strong insider score of 74/100, based on 18 past trades. Over a 12-month horizon, 53.8% of those trades were profitable, with an average 12-month return of +27.1%.
The LXEO filings lean toward selling, a net 205,202 shares.
Richard Nolan Townsend has 25 Form 4 filings on record from January 2024 to September 2026, all as Chief Executive Officer at Lexeo Therapeutics (LXEO), 2024–2026.
The 44 reported transactions were 23 open-market sales, 9 stock awards, 8 option exercises and 4 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 18 sales worth about $2.0M.
The largest open-market sale was 55,000 shares of LXEO at an average $16.79 on July 11, 2024, about $923K. Twelve months later LXEO was down 74%.
9 of the 18 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 9 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 3,345 | $4.95 | $16,561.76 | -0.9% | - | - | |
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 25,947 | $4.48 | $116,242.56 | -6.4% | -23.1% | - | |
| May 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 3,342 | $5.06 | $16,926.90 | -1.0% | +5.7% | - | |
| Apr 6, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 55,000 | $5.69 | $313,137.00 | -13.9% | -20.3% | - | |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 10,173 | $6.38 | $64,924.09 | -2.5% | -28.8% | - | |
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 1,127 | $9.27 | $10,447.29 | -0.5% | -31.6% | - | |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 13,133 | $8.94 | $117,436.00 | -5.1% | -21.7% | -72.4% | |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 2,735 | $4.67 | $12,766.98 | -1.2% | +92.7% | +0.2% | |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 1,074 | $2.77 | $2,979.28 | -0.5% | +47.8% | +57.1% | |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sell | 4,326 | $4.41 | $19,090.64 | -1.9% | -20.9% | +40.6% |